Skip to main content
Log in

Circadian variation in the pharmacokinetics of verapamil

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Circadian variation in the metabolism of verapamil was investigated in 10 patients with stable angina pectoris during treatment with sustained-release verapamil 360 mg at 08.00 h or 22.0 h.

No major difference in exercise parameters was found. During the evening dosage schedule a significantly greater bioavailability (AUC) and a prolonged time to peak concentration was found. During the night (24.00 h–06.00 h) the half-life of verapamil was significantly longer than during the day (16.00 h–22.00 h).

These differences in pharmacokinetics may be due to reduced hepatic blood flow at night or to circadian variation in hepatic microsomal metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Shively CA, Vesell ES (1975) Temporal variation in acetaminophen and phenacitin half-life in man. Clin Pharmacol Ther 18: 413–424

    Google Scholar 

  2. Reinberg A, Smolensky MH (1982) Circadian changes of drug disposition in man. Clin Pharmacokinet 7: 401–420

    Google Scholar 

  3. Smolensky MH, Alonzo GE (1988) Biologic rhythms and medicine. Am J Med 85 [Suppl 1B]: 34–46

    Google Scholar 

  4. Vener JK, Moore JG (1988) Chronobiologic properties of the alimentary canal affecting xenobiotic absorption. Annu Rev Chronopharmacol 4: 257–281

    Google Scholar 

  5. Lim CK, Rideout JM, Sheldon JNS (1983) Determination of verapamil and norverapamil in serum by high-performance liquid chromatography. J Liquid Chromatogr 6: 877–893

    Google Scholar 

  6. Jespersen CM, Klitgaard NA, Nielsen H, Hansen JF (1989) Sustained-release and instant-release verapamil in treatment of angina pectoris. Eur J Clin Pharmacol 36: 625–627

    Google Scholar 

  7. Alvan G, Grind M, Graffner C, Sjøquist F (1984) Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphism. Clin Pharmacol Ther 36: 515–519

    Google Scholar 

  8. Woodcock BG, Schulz W, Kober G, Rietbrock N (1981) Direct determination of hepatic extraction of verapamil in cardiac patients. Clin Pharmacol Ther 30: 52–56

    Google Scholar 

  9. Schomerus M, Spiegelhalder B, Stieren B, Eichelbaum M (1976) Physiological disposition of verapamil in man. Cardiovasc Res 10: 1–8

    Google Scholar 

  10. Goo RH, Moore JG, Greenberg E, Alazraki NP (1987) Circadian variation in gastric emptying of meals in humans. Gastroenterology 93: 515–518

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jespersen, C.M., Frederiksen, M., Hansen, J.F. et al. Circadian variation in the pharmacokinetics of verapamil. Eur J Clin Pharmacol 37, 613–615 (1989). https://doi.org/10.1007/BF00562555

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00562555

Key words

Navigation